Loading clinical trials...
Loading clinical trials...
The University of Michigan is conducting a study investigating a potential new treatment aimed at slowing/halting progression of primary biliary cirrhosis. This will be a 2 arm double blind study in w...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
George Brewer
Collaborators
NCT06519162 · Autoimmune Hepatitis, Primary Sclerosing Cholangitis, and more
NCT02931513 · Primary Biliary Cirrhosis, Liver Inflammation, and more
NCT04526665 · Primary Biliary Cirrhosis
NCT03301506 · Primary Biliary Cirrhosis
NCT03743272 · Liver Diseases, Primary Biliary Cirrhosis, and more
University of Michigan
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions